Improvements of an oral anti-cancer drug safety management program for patients with cancer
Asia-Pacific Journal of Oncology Nursing · 2026-12 · 13 · 100833
DOI: 10.1016/j.apjon.2025.100833 ↗Kurz gefasst
Fachartikel in der Zeitschrift Asia-Pacific Journal of Oncology Nursing, 2026-12. Verfasst von Hong Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Nursing Department, Peking University Cancer Hospital & …. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Objective
To evaluate the impact of an oral anti - cancer drug safety management program on nurses and patients.
Methods
This study was a hospital-level quality-improvement evaluation (pre-post, quasi-experimental design) and was not registered as a clinical trial. It was conducted from August 2024 to December 2024 in a tertiary hospital in Beijing. The program comprised three stages: preparation, training, implementation and supervision. It included tiered training for nurses based on established nursing standards, standardized health education checklists for patients, and continuous support through virtual and in-person clinic visit. Associated improvements were evaluated using self-designed questionnaires. Data were collected from nurses before training and 2 months after program implementation, and from patients before and 1 month after education. Descriptive statistics and non-parametric paired sample tests were used for analysis.
Results
A total of 632 nurses participated in the program, of which 381 nurses completed both evaluations. The knowledge and behavior scores of nurses regarding on correct medication administration, protection against drug exposure, and early management of adverse reactions improved significantly (P < 0.001). The full-score rates for knowledge and behavior increased from 71.82% and 71.55% to92.65% and 94.49%, respectively (Z = -11.462, -13.104, respectively; both P < 0.001). A total of 643 patients received guidance, of which 384 patients completed both evaluations. The knowledge and behavior scores of patients also improved significantly (P < 0.001), with the full-score rates increasing from 59.46% and 68.29% to78.62% and 85.11%, respectively (Z = -11.473, -12.415, respectively; both P < 0.001).
Conclusions
Meaningful improvements were achieved through enhancements to the oral anti-cancer drug safety management program. Standardized training and structured implementation enabled nurses to provide evidence-based patient guidance, thereby enhancing patients' knowledge and skills in safe medication management.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Nursing Department, Peking University Cancer Hospital & Institute, Beijing, China.
- School of Nursing, Peking University, Beijing, China.
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Day Oncology Unit, Peking University Cancer Hospital & Institute, Beijing, China.
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Breast Oncology, Peking University Cancer Hospital & Institute, Beijing, China.
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing, China.
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Hepatopancreatobiliary Surgery I, Peking University Cancer Hospital & Institute, Beijing, China.
Zitieren
APA
Yang, H., Zhang, H., Zhou, J., Li, H., Guo, R., Zhang, H., You, M., Zhang, L., Liu, W., & Lu, Y. (2026). Improvements of an oral anti-cancer drug safety management program for patients with cancer. Asia-Pacific Journal of Oncology Nursing, 13, 100833. https://doi.org/10.1016/j.apjon.2025.100833
Vancouver
Yang H, Zhang H, Zhou J, Li H, Guo R, Zhang H, et al. Improvements of an oral anti-cancer drug safety management program for patients with cancer. Asia-Pacific Journal of Oncology Nursing. 2026;13:100833. doi:10.1016/j.apjon.2025.100833
BibTeX
@article{Yang2026,
author = {Yang, Hong and Zhang, Hong and Zhou, Jingjuan and Li, Hongli and Guo, Renxiu and Zhang, Hong and You, Miaoning and Zhang, Liyan and Liu, Wanrong and Lu, Yuhan},
title = {Improvements of an oral anti-cancer drug safety management program for patients with cancer},
journal = {Asia-Pacific Journal of Oncology Nursing},
year = {2026},
volume = {13},
pages = {100833},
doi = {10.1016/j.apjon.2025.100833}
}
EUVIMED